These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20210988)

  • 1. Decreased HIV diversity after allogeneic stem cell transplantation of an HIV-1 infected patient: a case report.
    Kamp C; Wolf T; Bravo IG; Kraus B; Krause B; Neumann B; Winskowsky G; Thielen A; Werner A; Schnierle BS
    Virol J; 2010 Mar; 7():55. PubMed ID: 20210988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
    Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
    Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
    Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic analysis of human immunodeficiency virus type 1 env V3 loop sequences: bioinformatics prediction of coreceptor usage among 28 infected mother-infant pairs in a drug-naive population.
    Duri K; Soko W; Gumbo F; Kristiansen K; Mapingure M; Stray-Pedersen B; Muller F;
    AIDS Res Hum Retroviruses; 2011 Apr; 27(4):411-9. PubMed ID: 20969460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy.
    Raymond S; Saliou A; Delobel P; Cazabat M; Pasquier C; Jeanne N; Sauné K; Massip P; Marchou B; Izopet J
    J Antimicrob Chemother; 2014 Sep; 69(9):2527-30. PubMed ID: 24840625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Analyses of HIV-1 Strains Transmitted from Mother to Child in Northern Vietnam.
    Phan CT; Pham HV; Bi X; Ishizaki A; Saina M; Phung CD; Khu DT; Ichimura H
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):797-805. PubMed ID: 25826000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seminal reservoirs during an HIV type 1 eradication trial.
    Nunnari G; Leto D; Sullivan J; Xu Y; Mehlman KE; Kulkosky J; Pomerantz RJ
    AIDS Res Hum Retroviruses; 2005 Sep; 21(9):768-75. PubMed ID: 16218800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic coreceptor analysis.
    Sierra S; Kaiser R; Thielen A; Lengauer T
    Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and phenotypic features of blood and genital viral populations of clinically asymptomatic and antiretroviral-treatment-naive clade a human immunodeficiency virus type 1-infected women.
    Andreoletti L; Skrabal K; Perrin V; Chomont N; Saragosti S; Gresenguet G; Moret H; Jacques J; Longo Jde D; Matta M; Mammano F; Belec L
    J Clin Microbiol; 2007 Jun; 45(6):1838-42. PubMed ID: 17460054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and genetic evolution of HIV type 1 in two siblings with different patterns of disease progression.
    Ripamonti C; Leitner T; Laurén A; Karlsson I; Pastore A; Cavarelli M; Antonsson L; Plebani A; Fenyö EM; Scarlatti G
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1531-40. PubMed ID: 18160011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of R5 and X4 HIV variants in antiretroviral treatment experienced patients with virologic failure.
    Ferrer P; Tello M; Montecinos L; Tordecilla R; Rodríguez C; Beltrán C; Guzmán MA; Ferrés M; Pérez CM; Afani A
    J Clin Virol; 2014 Jul; 60(3):290-4. PubMed ID: 24793966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism.
    Soulié C; Charpentier C; Flandre P; Nino C; Carcelain G; Simon A; Katlama C; Landman R; Brun-Vézinet F; Descamps D; Calvez V; Marcelin AG
    J Med Virol; 2012 Dec; 84(12):1853-6. PubMed ID: 23080487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
    J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity.
    Skrabal K; Saragosti S; Labernardière JL; Barin F; Clavel F; Mammano F
    J Virol; 2005 Sep; 79(18):11848-57. PubMed ID: 16140761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4-dependent characteristics of coreceptor use and HIV type 1 V3 sequence in a large population of therapy-naive individuals.
    Low AJ; Marchant D; Brumme CJ; Brumme ZL; Dong W; Sing T; Hogg RS; Montaner JS; Gill V; Cheung PK; Harrigan PR
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):219-28. PubMed ID: 18240966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected coreceptor usage of primary human immunodeficiency virus type 1 isolates from viremic patients under highly active antiretroviral therapy.
    Holtkamp N; Otteken A; Findhammer S; Miller V; Kurth R; Werner A
    J Infect Dis; 2000 Feb; 181(2):513-21. PubMed ID: 10669334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.